Latest Financial Performance Reports News

AFT Pharmaceuticals has reported record revenue of NZD 208 million for FY25, driven by strong Australasian sales and a recovery in Asia and international markets. The company is targeting NZD 300 million in revenue by FY27, supported by an expanded R&D pipeline and ongoing geographic diversification.

Capstone Copper delivered a standout first quarter in 2025 with record sulphide copper output and adjusted EBITDA more than doubling year-over-year, underpinning its confidence in meeting full-year guidance and advancing key growth projects.

South32 Limited reported a strong first half of fiscal 2025, driven by improved operational performance and a streamlined portfolio following the sale of Illawarra Metallurgical Coal. The company announced a fully-franked interim dividend and maintained its production guidance despite some operational challenges.

Argo Investments reports a robust half-year profit of $121.2 million and announces a record fully franked interim dividend of 17.0 cents per share, driven by increased dividend revenue and strategic portfolio moves.